Literature DB >> 7228352

Inhibition of mast-cell degranulation by chemotactic peptides.

J M Gleisner, C A Ramthun, J C Houck.   

Abstract

Pepstatin and f-methionyl peptides which are potent chemotactic agents for neutrophils were found to inhibit the increase in vascular permeability of rat skin which follows the injection of 48/80, anti-rat IgE serum, or pulmonary permeability factor. These latter compounds are known to act by releasing histamine from mast cells. f-Met-Leu-Phe, which is the most active chemotactically, was also found to be the most active inhibitor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228352     DOI: 10.1007/bf00910775

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  10 in total

1.  The chemical synthesis of pepstatin A.

Authors:  H Morishima; T Takita; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1972-09       Impact factor: 2.649

2.  Effects of cortisol released cutaneous protease upon the permeability of the micro-circulation.

Authors:  A W Lykke; D A Willoughby; J C Houck
Journal:  J Invest Dermatol       Date:  1967-04       Impact factor: 8.551

3.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes.

Authors:  H Umezawa; T Aoyagi; H Morishima; M Matsuzaki; M Hamada
Journal:  J Antibiot (Tokyo)       Date:  1970-05       Impact factor: 2.649

4.  Permeability factor contaminating hyaluronidase preparations.

Authors:  J C Houck; C M Chang
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

5.  Macromolecular, anionic pulmonary permeability factor.

Authors:  J C Houck; J M Gleisner; C M Chang
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

6.  Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.

Authors:  S Aswanikumar; B Corcoran; E Schiffmann; A R Day; R J Freer; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

7.  Pepstatin A--a human leukocyte chemoattractant.

Authors:  S K Ackerman; S D Douglas
Journal:  Clin Immunol Immunopathol       Date:  1979-10

8.  Cytotaxin receptors of neutrophils: evidence that F-methionyl peptides and pepstatin share a common receptor.

Authors:  R D Nelson; S K Ackerman; V D Fiegel; M P Bauman; S D Douglas
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

9.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

  10 in total
  2 in total

1.  Distinct patterns of granulocyte luminol-dependent chemiluminescence response to lectins WGA and RCA-I.

Authors:  K E Magnusson; C Dahlgren; A Sjölander
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

2.  Effect of N-formylated methionyl-phenylalanine (FMP) and methionyl-leucyl-phenylalanine (FMLP) on gut permeability. A model of local inflammatory process.

Authors:  K E Magnusson; C Dahlgren; A Sjölander
Journal:  Inflammation       Date:  1985-12       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.